Kristen Hege's Net Worth

$79.7 Thousand

Estimate Recalculated Apr 3, 2024 07:17PM EST

Who is Kristen Hege?

Kristen Hege does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mersana Therapeutics, Inc., Graphite Bio, Inc., Arcus Biosciences, Inc., CELL GENESYS INC, and Adaptimmune Therapeutics PLC.

SEC CIK

Kristen Hege's CIK is 0001299171

Past Insider Trading and Trends

2023 was Kristen Hege's most active year for acquiring shares with 6 total transactions. Kristen Hege's most active month to acquire stocks was the month of May. 2008 was Kristen Hege's most active year for disposing of shares, totalling 1 transactions. Kristen Hege's most active month to dispose stocks was the month of June. 2004 saw Kristen Hege paying a total of $216,300.00 for 30,000 shares, this is the most they've acquired in one year. In 2008 Kristen Hege cashed out on 9,051 shares for a total of $28,103.35, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 2
Form 4
—
0
—
—
0
Jul 3
Form 4
∞
14.47K
—
—
14.47K
Jun 8
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Jan 2
Form 3
—
0
—
—
0
No matching records found

Graphite Bio, Inc. (GRPH) Snapshot price: $2.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 19
Form 4
—
0
—
—
0
Jun 21
Form 3
—
0
—
—
0
No matching records found

Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Oct 19
Form 3
—
0
—
—
0
No matching records found

CELL GENESYS INC No price found

VP Clinical Research

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.75%
-9.05K
$3.11
-$28,103.35
27.51K
Jul 31
Form 4
—
0
—
—
0
Feb 6
Form 4
+216.21%
25K
—
—
36.56K
Jul 30
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 7
Form 4
+7.81%
500
$5.35
$2,675.00
6.9K
Jun 9
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Jul 30
Form 3
—
0
—
—
0
No matching records found

Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 15
Form 3
—
0
—
—
0
No matching records found